Literature DB >> 21119054

Continuing education course #2: current understanding of hemostasis.

Andrew J Gale1.   

Abstract

The goal of this review is to briefly summarize the two primary pathways of hemostasis, primary hemostasis and secondary hemostasis, as well as to summarize anticoagulant mechanisms and fibrinolysis. In addition, this review will discuss pathologies of hemostasis and the mechanisms of the various drugs that are available to impact these pathways to prevent either thrombosis or bleeding. While many of the main drugs that are used to treat disorders of hemostasis have been used for decades, greater understanding of hemostasis has led to development of various new drugs that have come onto the market recently or are close to coming onto the market. Thus, improved understanding of hemostasis continues to lead to benefits for patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119054      PMCID: PMC3126677          DOI: 10.1177/0192623310389474

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  65 in total

1.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

Authors:  T K Vu; D T Hung; V I Wheaton; S R Coughlin
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

Review 2.  Molecular basis of vitamin K-dependent gamma-carboxylation.

Authors:  B Furie; B C Furie
Journal:  Blood       Date:  1990-05-01       Impact factor: 22.113

Review 3.  Surface-dependent reactions of the vitamin K-dependent enzyme complexes.

Authors:  K G Mann; M E Nesheim; W R Church; P Haley; S Krishnaswamy
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

4.  Isolation and characterization of a platelet membrane protein related to the vitronectin receptor.

Authors:  S C Lam; E F Plow; S E D'Souza; D A Cheresh; A L Frelinger; M H Ginsberg
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

5.  Wall shear rate in arterioles in vivo: least estimates from platelet velocity profiles.

Authors:  G J Tangelder; D W Slaaf; T Arts; R S Reneman
Journal:  Am J Physiol       Date:  1988-06

6.  Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C.

Authors:  E R Guinto; C T Esmon
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

7.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

8.  The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.

Authors:  G J Broze; L A Warren; W F Novotny; D A Higuchi; J J Girard; J P Miletich
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

9.  Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.

Authors:  K Hanasaki; H Arita
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

10.  Laminin receptor on platelets is the integrin VLA-6.

Authors:  A Sonnenberg; P W Modderman; F Hogervorst
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

View more
  47 in total

1.  Feeling the Force: Measurements of Platelet Contraction and Their Diagnostic Implications.

Authors:  Evelyn Kendall Williams; Oluwamayokun Oshinowo; Abhijit Ravindran; Wilbur A Lam; David R Myers
Journal:  Semin Thromb Hemost       Date:  2018-12-19       Impact factor: 4.180

Review 2.  Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?

Authors:  Margaret Spinosa; Jonathan G Stine
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

3.  Fabrication of injectable and superelastic nanofiber rectangle matrices ("peanuts") and their potential applications in hemostasis.

Authors:  Shixuan Chen; Mark A Carlson; Yu Shrike Zhang; Yong Hu; Jingwei Xie
Journal:  Biomaterials       Date:  2018-06-22       Impact factor: 12.479

Review 4.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 5.  Peptide-based topical agents and intravenous hemostat for rapid hemostasis.

Authors:  Snehasish Ghosh; Archana Tripathi; Paramita Gayen; Rituparna Sinha Roy
Journal:  RSC Med Chem       Date:  2020-10-08

6.  Magnitude and Associated Factors of Thrombocytopenia among Pregnant Women Attending Antenatal Care Clinics at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.

Authors:  Hussen Ebrahim; Bizuneh Kebede; Mihret Tilahun; Habtu Debash; Habtye Bisetegn; Melkam Tesfaye
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

Review 7.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

Review 8.  Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases.

Authors:  Cijo George Vazhappilly; Shabbir Ahmed Ansari; Rula Al-Jaleeli; Aya Mudhafar Al-Azawi; Wafaa S Ramadan; Varsha Menon; Rawad Hodeify; Shoib Sarwar Siddiqui; Maxime Merheb; Rachel Matar; Rajan Radhakrishnan
Journal:  Inflammopharmacology       Date:  2019-07-15       Impact factor: 5.093

9.  Blood Flow Velocimetry in a Microchannel During Coagulation Using Particle Image Velocimetry and Wavelet-Based Optical Flow Velocimetry.

Authors:  E Kucukal; Y Man; Umut A Gurkan; B E Schmidt
Journal:  J Biomech Eng       Date:  2021-09-01       Impact factor: 1.899

10.  Modern Management of Bleeding, Clotting, and Coagulopathy in Trauma Patients: What Is the Role of Viscoelastic Assays?

Authors:  Sanjeev Dhara; Ernest E Moore; Michael B Yaffe; Hunter B Moore; Christopher D Barrett
Journal:  Curr Trauma Rep       Date:  2020-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.